The African Journal of Oncology, a biannual journal, publishes articles on medical oncology, surgical oncology, radiotherapy, pharmacology, epidemiology, biology and basic cancer research.
The publications are presented in the form of editorials, original articles, review articles, letters to the editor, news, open forums.
Publications are in English or French.

Publication policy
The principal author should have played a leading role in the conduct of the reported work and in the writing of the work. Published work must conform to standards set by the Vancouver group (International Committee of Medical Journal Editors – ICMJE (
The work submitted complies with the ethical recommendations of the Declaration of Helsinki (The Code of Ethics of the World Medical Association) and must have been submitted, if required, to an ethics committee.
The principal author accepts responsibility for the manuscript submitted to the African Journal of Oncology on behalf of the co-authors and must report on a possible conflict of interest.
The main author must assure the African Journal of Oncology that the ethical and legal arrangements have been made and, if necessary, provide proof thereof upon request of the journal.
The newspaper reserves the right to suspect and denounce plagiarism in case of doubt or upon simple verification by the editorial committee.

Submission and presentation of manuscripts
Articles are submitted in Microsoft™ Word© format, online at
The author submitting the article follows a path that allows them to submit their name, email address and phone number and upload the manuscript separately. The author who submits the article will receive the correspondence and the proof.
The manuscript is submitted with the following in the same document and in the following order:

  • The title in English and French,
  • The names of the authors marked with a number in superscript related to the affiliation,
  • The affiliations of the different authors according to their original services or their specialties,
  • The summary followed by key words in English and in French,
  • The text in English or in French,
  • Acknowledgments: they relate to scientific contributions, technical aids, material or financial support,
  • The declaration of mandatory conflict of interest with the mention, Conflict of interest: none, if applicable, give the name of the company involved in the conflict of interest and specify its implication in the article,
  • The declaration of ethics,
  • Bibliographical references,
  • The tables with an explanatory title placed above and numbered.
  • The figures with an explanatory title below and numbered followed by a legend if necessary. Target numbering is preferred over signage, followed by a caption below the title.

Presentation according to the type of article
The summary is 250 words long. It is presented in English and in French, without abbreviation or reference. The summaries are structured according to the IMRAD style: Introduction; Methods; Results; Discussion.
For clinical facts and technical notes, the abstract should not exceed 100 words, should give the essential results and a conclusion.
For reviews, the abstract should not exceed 250 words.

Text Drafting
The following formatting is recommended:

  • Font: Times New Roman,
  • Size: 12,
  • Line spacing: 1.5,
  • Space between paragraphs: 0,
  • Justified,
  • Bold and italics are allowed.

Drafting style
A simple and clear style is recommended. Only the first author is cited in the text.

Abbreviations, units of measurement and symbols
Abbreviations, symbols and measurements should conform to international standards. In case of fortuitous abbreviations, they must be specified.
Medicines are identified by their generic name (international non-proprietary name), without the initials. If necessary, the specialty name of a drug is followed by the acronym ® and the trade name of a device by the acronym TM.
The numbers zero to ten are written in full.

References appear at the end of the article, numbered according to the order in which they appear in the text, even if they relate to tables and figures. They are identified in the text by Arabic numerals in square brackets. The numbers are separated by commas when it comes to two consecutive digits or not, and by hyphens when it comes to at least three consecutive digits and only the extreme digits are then quoted (for example [10, 11], [1, 2, 7-9, 10]).
Abstracts of published oral or poster communications may be cited; the mention [abstract] or [résumé], depending on whether the reference is in English or in French, appears after the title. Letters to the editor are marked with [letter] or [lettre] after the title. Up to five authors, these must be mentioned by name; from six, only the first five will be cited, followed by a comma and the words “et al.”.
References are presented in accordance with Vancouver standards which can be found at this link:

Examples of references:
Classic periodical article
[1] Troussier B, Marchou-Lopez S, Pironneau S, Alais E, Grison J, Pref G, et al. Back pain and spinal alignment abnormalities in school children. Rev Rhum 1999;66: 370–80.
Part of a supplement to a volume
[2] Bas S, Vischer TL. Humoral immunity in Chlamydia trachomatis arthritis. Rev Rhum 1999; 1 Suppl: 34–6.
[3] Kanis JA, ed. Pathology and treatment of Paget’s disease of bone. London: Martin Dunitz; 1991.
Book chapter
[4] Schumacher HR. Sarcoidosis. In: McCarthy DJ, Ed. Arthritis and allied conditions, 11th ed. Philadelphia: Lea and Febiger; 1989: 1294-300.
Congress report
[5] Gammage RB, Kaye SV. Indoor air and human health. Proceedings of the 7th Life Sciences Symposium,1984 Oct. 29-31; Knoxville (TN), Chelsea (MI): Lewis; 1985. p. 69-78.
[6] Bernard MN. Qualité de vie et état nutritionnel des insuffisances respiratoires chroniques graves [thèse]. Grenoble : Université Joseph-Fourier; 1997. p. 1-153.
Reference available in electronic format
[7] Morse SS. Factors in the emergence of infectious diseases. Emerg Infect Dis [serial online] 1995 Jan-Mar [cited 1996 Jun 5]; 1: [24 screens]. Available from: URL:

The section of interest to the author must be mentioned upon submission.

The author presents a theme or an opinion. The editorial can draw attention to a hot topic or journal article; the author can ask a question and provide an answer with arguments. Editorials should not contain original results or clinical observations. They must be brief (7,000 characters, spaces included) and have less than ten references. They can be submitted spontaneously or requested by the Editorial Board.

The original articles
They must present unpublished results and not be submitted for publication to another journal. Original articles cannot exceed 20 typed pages and include: an introduction, results, materials and methods, discussion, bibliographic references (40 maximum), Acknowledgments, a summary in English and in French of 250 words maximum, and three to six Keywords. Particular attention must be paid to the drafting of summaries because they then appear in the databases (IMRAD structuring). It is the same with regard to the choice of keywords. All information present in the summaries must be explicitly developed in the text. The title is very important. It should be clear and as brief as possible, not exceeding 120 characters. A short title should be offered.

These articles aim to present an update of knowledge, to underline recent acquisitions, to clearly show how progress in biology and medicine go hand in hand and, finally, to draw attention to still unresolved questions. for educational purposes. Articles should not exceed 20 typed pages (not including references, diagrams, tables and their captions). Each article must include an informative abstract in English and in French of approximately 250 words, as well as the corresponding keywords (three to six) used to reference the article in the databases. Authors who are unfamiliar with English are strongly encouraged to have their text proofread by an English-speaking person. The editors reserve the right to make corrections as they deem necessary. Articles may include up to six illustrations, tables or figures. Bibliographical references should not claim to be exhaustive but rather selectivity: their number should not exceed 30.

Letter to the Editor
They can relate to preliminary results of a study, scientific or professional information. This section also allows an exchange between the readers and the authors or the editorial staff, a response being able to be published afterwards. They can also touch on topical issues. Letters to the editor must not exceed 5,000 characters and one table or figure. The number of authors should not exceed five and the number of references should be limited to ten. There is no abstract. If the letter is the subject of a clinical case, he must report an original fact: first observation of a clinical fact, unexpected therapeutic effect, unexpected side effect, etc. It is not useful to report a relatively rare fact which has already been published several times, nor the fortuitous association of two rare diseases.

News reports recent information that has been the subject of one or more publications. They are limited to two typed pages, must include an English and French title and up to five references.

Free stand
This section concerns updates, hypotheses, free opinions, controversies or various comments. The Editorial Board also reserves the right to publish short letters from readers (One typed page, an English and French title and two or three references), about recently published articles, as well as the authors’ responses.

Proof corrections, offprints, request for reproduction
When the manuscript accepted for publication goes into production, the publisher will email the corresponding author. This document must be completed and signed by the corresponding author on behalf of all authors, then returned to the editor as soon as possible. The proofs will be sent to the author by email (pdf format). No proof may be substantively corrected, regardless of the type of substantive corrections. Only typographical errors can be corrected. No additions can be made to the manuscript definitively accepted.
In the event of long delays, the publisher reserves the right to proceed with the printing, after agreement from the editorial staff, without the author’s proof. In all circumstances, the editorial staff reserves the right to make the necessary editorial corrections as a last resort.

Date of up-to-date: May, 28th 2021.